Effects of secretory PLA2 on rat peritoneal mast cells activated by different secretagogues.
Lau
H Y
HY
Department of Pharmacology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Roche
C M
CM
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D015220:Calcium Channels / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D054501:Group II Phospholipases A2; D006636:Histamine Release / Q000187:drug effects*; D007476:Ionophores / Q000494:pharmacology; D007527:Isoenzymes / Q000502:physiology*; D008297:Male; D008407:Mast Cells / Q000187:drug effects* / Q000378:metabolism; D008563:Membrane Lipids / Q000378:metabolism; D010529:Peritoneal Cavity / Q000166:cytology*; D010741:Phospholipases A / Q000494:pharmacology*; D054467:Phospholipases A2; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D000888:Antibodies, Anti-Idiotypic; D015220:Calcium Channels; D004791:Enzyme Inhibitors; D007476:Ionophores; D007527:Isoenzymes; D008563:Membrane Lipids; D010743:Phospholipids; C026408:anti-IgE antibodies; D000001:Calcimycin; D003189:p-Methoxy-N-methylphenethylamine; D010741:Phospholipases A; D054501:Group II Phospholipases A2; D054467:Phospholipases A2